Even when the brain's background inhibitory signal is boosted using a drug that increases GABA, it still can't stop abnormal electrical bursts in rat hippocampus tissue when magnesium is lowered to trigger seizures.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether GAT-1 inhibition consistently fails to reduce seizure frequency or severity across animal models of epilepsy, and whether this failure correlates with receptor saturation.
A systematic review and meta-analysis of all studies (n≥25) using GAT-1 inhibitors (NO-711, tiagabine) in rodent seizure models (e.g., kainate, pilocarpine, 4-AP, low Mg2+), measuring seizure duration, frequency, and EEG power, with subgroup analysis by brain region and GABA receptor subtype.
Whether NO-711 reduces seizure-like activity in live rats with induced epilepsy compared to placebo.
A double-blind, randomized trial in 60 rats with chronic epilepsy induced by kainate injection, randomized to receive NO-711 (10 mg/kg i.p.) or vehicle twice daily for 14 days, with continuous EEG monitoring to quantify seizure burden and neuronal loss via histology.
Whether individuals with higher GABA transporter expression show lower seizure frequency in epilepsy.
A prospective cohort study of 200 patients with drug-resistant temporal lobe epilepsy, measuring GAT-1 expression in resected hippocampal tissue via immunohistochemistry, and correlating it with pre-surgical seizure frequency and response to GABAergic drugs.
Whether patients with frequent seizures have lower GAT-1 expression or GABA uptake capacity compared to those with infrequent seizures.
A case-control study comparing GAT-1 protein levels in hippocampal tissue from 50 patients with high-frequency seizures (>10/month) and 50 with low-frequency seizures (<1/month), matched for epilepsy duration and medication, using Western blot and uptake assays.
Whether hippocampal GABA levels measured by MRS correlate with seizure frequency in living epilepsy patients.
A cross-sectional study of 120 epilepsy patients using 7T MRS to measure hippocampal GABA and correlating it with seizure frequency over the prior 6 months, controlling for antiepileptic drug levels and lesion type.